Prime Medicine, Inc.
USD3.77
+0.04 (+1.21%)
CEO
Allan Reine
IPO Date
2022-10-20
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$3.77
Prev. Close
$3.72
Day Low
$3.65
Day High
$3.78
52W Low
$2.28
52W High
$6.94
Market Cap
$0.68B
Volume
0.40M
| -1.8 |
| 31 Dec 2023 | FY | 0.0% | 0.0% | -148.9% | -102.2% | 0.10 | 2.53 | -4.1 |
| 31 Dec 2022 | FY | 0.0% | 0.0% | -38.5% | -33.8% | 0.09 | 11.10 | -14.8 |
| 31 Dec 2021 | FY | 0.0% | 0.0% | -69.0% | -54.8% | 0.04 | 4.67 | -8.9 |
| 31 Dec 2020 | FY | 42.8% | -65.5% | -10.2% | -6.2% | 0.00 | 2.75 | -431.5 |
| 31 Dec 2019 | FY | 0.0% | 0.0% | -182.1% | -29.1% | 0.00 | 1.19 | -581.8 |
| -2.8 |
| 30 Sept 2025 | Q3 | -3491.0% | -4129.1% | -31.3% | -13.1% | 0.73 | 6.61 | -4.4 |
| 30 Jun 2025 | Q2 | -67.2% | -4716.7% | -86.4% | -18.8% | 1.97 | 3.56 | -1.5 |
| 31 Mar 2025 | Q1 | 100.0% | -3568.8% | -48.5% | -15.8% | 1.13 | 4.78 | -1.3 |
| 31 Dec 2024 | Q4 | 100.0% | -1936.6% | -27.6% | -14.2% | 0.27 | 5.58 | -2.0 |
| 30 Sept 2024 | Q3 | 100.0% | -25128.2% | -27.7% | -15.8% | 0.22 | 6.50 | -2.2 |
| 30 Jun 2024 | Q2 | 0.0% | 0.0% | -28.1% | -21.3% | 0.21 | 8.23 | -3.0 |
| 31 Mar 2024 | Q1 | -122.5% | -7743.0% | -18.8% | -14.7% | 0.18 | 8.91 | -3.9 |
| 31 Dec 2023 | Q4 | 0.0% | 0.0% | -49.3% | -33.9% | 0.10 | 2.53 | -3.3 |